Plus, the private credit exodus is spreading...
UBS upgrades Knight-Swift Transportation on tightening truckload supply and rising spot rates.
Plus, OpenAI's 'wake-up call' moment...
Barclays upgrades Align Technology to Overweight on a conflict-driven pullback.
Plus, a developing story that airline CEOs find 'simply unacceptable'...
Jefferies calls Abivax's ulcerative colitis drug a differentiated winner in a market headed for $30 billion.
One company is quietly building an AI, drone, and missile defense platform as global security threats intensify.
Plus, Inverse Cramer: the one trade signal we can still count on...
Plus, a quiet winner of the US defense budget, a COVID-era darling due for a resurgence, and a top-tier analyst’s contrarian call carrying more than 100% upside potential.
It might not be long before America feels it.
Surging oil prices have revived stagflation fears.
Meta copy
Plus, Elon Musk calls a mulligan...
JPM believes a tightened global helium supply could favor this industrial gas giant's unique reserves.
Plus, the largest housing affordability bill in 30 years...
Citi upgrades Dow to Buy as Middle East tensions drive commodity chemical prices higher.
Plus, your next burger order may be delivered by a robot...
Barclays upgrades Nike to Overweight as North America reset shows early signs of progress.
Plus, another blockbuster IPO joins the slate...
TD Cowen upgrades Rivian to Buy ahead of the R2 SUV launch.
Plus, meet OpenAI's newest subsidiary...
Goldman Sachs says rising oil prices could boost one Chinese gas giant's free cash flow by more than 10%.
Plus, three key labor data points you might have missed...
Plus, a beaten-down enterprise play with more than 100% upside potential, a bitcoin miner with a repositioning plan that caught the eye of a Top 1% analyst, and more.
Here’s everything you might have missed last week on Wall Street, and everything to watch in the week ahead.
